Deregulated PSGL-1 Expression in B Cells and Dendritic Cells May Be Implicated in Human Systemic Sclerosis...

Area of Science:

• Immunology
• Autoimmune Diseases
• Cell Biology

Background:

• Systemic sclerosis (SSc) is a severe autoimmune disease with limited treatment options.
• PSGL-1 (P-selectin glycoprotein ligand-1) is a leukocyte receptor, and ADAM8 (a disintegrin and metalloproteinase domain-8) is a protease implicated in inflammation.
• Dysregulation of these molecules may contribute to SSc pathogenesis.

Purpose of the Study:

• To investigate the role of PSGL-1 and ADAM8 in the development of human SSc.
• To assess PSGL-1 and ADAM8 expression patterns in SSc patients and correlate them with disease characteristics.

Main Methods:

• Flow cytometry was used to analyze PSGL-1 and ADAM8 expression on immune cells from SSc patients and healthy controls.
• Functional assays examined PSGL-1-mediated signaling in monocytes.
• IL-10 production by B cells was measured.
• Multivariate analysis identified potential diagnostic markers.

Main Results:

• SSc patients showed increased PSGL-1 on monocytes, dendritic cells, and T cells, but decreased expression on B cells.
• Monocytes from SSc patients had impaired PSGL-1 signaling.
• PSGL-1-expressing B cells from SSc patients produced less IL-10.
• ADAM8 expression was elevated on antigen-presenting cells and T lymphocytes in SSc patients.
• High ADAM8 on plasmacytoid dendritic cells distinguished SSc patients from controls.
• Increased PSGL-1 on dendritic cells correlated with interstitial lung disease.

Conclusions:

• PSGL-1 and ADAM8 are dysregulated in SSc, affecting immune cell function and potentially contributing to disease pathogenesis.
• ADAM8 expression on plasmacytoid dendritic cells may serve as a diagnostic biomarker for SSc.
• PSGL-1 expression on dendritic cells is associated with interstitial lung disease in SSc.